Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Methoxyflurane inhalation - Medical Developments International

Next Previous
Drug Profile

Methoxyflurane inhalation - Medical Developments International

Alternative Names: Anecotan; Green whistle; ME-MEOTH; Methofane; Methoflurane; Methofluranum; Methoxane; Methoxyfluran; Metofane; Metoxifluran; NSC-110432; Penthrane; Penthrop; Penthrox; PENTHROX; Penthrox-3; Pentran; Pentrane

Latest Information Update: 13 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medical Developments International
  • Developer LINK Healthcare; Medical Developments International; Purdue Pharma
  • Class Analgesics; Fluorinated hydrocarbons; General anaesthetics; Methyl ethers; Muscle relaxants; Non-opioid analgesics; Small molecules
  • Mechanism of Action GABA receptor modulators; Gap junction modulators; Glutamate receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 29 Apr 2025 Methoxyflurane inhalation licensed to Ethypharm for marketing and distribution in France
  • 29 Apr 2025 Ethypharm plans to commence its commercial activities for Methoxyflurane inhalation in France in July 2025
  • 28 Dec 2024 No recent reports of development identified for preclinical development in Pain in China (Inhalation, Liquid)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top